For PCOS patients, Letrozole often leads to higher pregnancy rates than Clomid. Studies show a slightly improved live birth rate with Letrozole compared to Clomid.
However, Clomid’s side effects, including hot flashes and ovarian cysts, are generally considered milder than Letrozole’s, which can cause more severe side effects like headaches and vision changes. Letrozole also carries a slightly higher risk of multiple pregnancies.
Both medications increase the risk of ovarian hyperstimulation syndrome (OHSS), although this risk is relatively low. OHSS symptoms include abdominal pain, bloating, and weight gain. Severe OHSS requires hospitalization.
Regarding birth defects, current research doesn’t indicate a significantly higher risk with either drug, though this remains an area of ongoing study.
The best choice depends on individual factors. Your doctor will consider your medical history, age, and overall health to recommend the safest and most suitable treatment.
Regular monitoring during treatment is crucial for both medications. Ultrasound scans track follicle development, allowing for dose adjustments and minimizing risks.
Open communication with your doctor about your concerns and experience with either drug is vital for optimal care.
